A Randomized Open Blind Control Study Assessing Clopidogrel Resistance in Iranian Patients Undergoing Percutaneous Coronary Intervention in Rajaie Heart Center

AuthorHosein ali Basirien
AuthorBahram Fariborz Farsaden
Issued Date2012-08-30en
AbstractThe prevalence of response variability to clopidogrel in Iranian patients undergoing elective percutaneous coronary intervention (PCI) with stenting, impleta has not been fully investigated. We evaluated clopidogrel antiplatelet effects of 300 mg versus a 450 mg in open blind randomized clinical trial in a referral teaching hospital in Iran.en
DOIhttps://doi.org/en
KeywordA Randomizeden
KeywordPercutaneous Coronaryen
PublisherBrieflandsen
TitleA Randomized Open Blind Control Study Assessing Clopidogrel Resistance in Iranian Patients Undergoing Percutaneous Coronary Intervention in Rajaie Heart Centeren
TypeResearch Articleen

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
Pages from Vol.4 No.2 Vol.4 No.3 August 2012.pdf
Size:
261.4 KB
Format:
Adobe Portable Document Format
Description:
Article/s PDF